Atlas Capital Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.45M | Sell |
33,386
-2,433
| -7% | -$217K | 0.38% | 70 |
|
|
2026
Q1 | $2.57M | Sell |
35,819
-1,412
| -4% | -$109K | 0.29% | 79 |
|
|
2025
Q4 | $2.95M | Buy |
+37,231
| New | +$2.94M | 0.33% | 74 |
|
|
2025
Q2 | $1.39M | Buy |
20,174
+3,276
| +19% | +$215K | 0.17% | 110 |
|
|
2025
Q1 | $1.14M | Buy |
16,898
+15,817
| +1,463% | +$947K | 0.14% | 131 |
|
|
2024
Q4 | $48.5K | Sell |
1,081
-600
| -36% | -$33.7K | 0.01% | 615 |
|
|
2024
Q3 | $106K | Hold |
1,681
| – | – | 0.02% | 487 |
|
|
2024
Q2 | $99.3K | Sell |
1,681
-3,420
| -67% | -$214K | 0.01% | 499 |
|
|
2024
Q1 | $407K | Buy |
5,101
+858
| +20% | +$65.5K | 0.06% | 248 |
|
|
2023
Q4 | $335K | Sell |
4,243
-158
| -4% | -$11.2K | 0.05% | 288 |
|
|
2023
Q3 | $307K | Hold |
4,401
| – | – | 0.05% | 275 |
|
|
2023
Q2 | $304K | Sell |
4,401
-1,016
| -19% | -$72.3K | 0.05% | 288 |
|
|
2023
Q1 | $403K | Sell |
5,417
-9,057
| -63% | -$759K | 0.06% | 228 |
|
|
2022
Q4 | $1.35M | Buy |
14,474
+351
| +2% | +$33.9K | 0.23% | 86 |
|
|
2022
Q3 | $1.35M | Buy |
14,123
+6,313
| +81% | +$625K | 0.25% | 77 |
|
|
2022
Q2 | $724K | Sell |
7,810
-5,935
| -43% | -$579K | 0.12% | 141 |
|
|
2022
Q1 | $1.39M | Buy |
13,745
+3,498
| +34% | +$367K | 0.22% | 96 |
|
|
2021
Q4 | $1.06M | Sell |
10,247
-195
| -2% | -$18K | 0.16% | 108 |
|
|
2021
Q3 | $886K | Buy |
10,442
+225
| +2% | +$18.8K | 0.14% | 124 |
|
|
2021
Q2 | $853K | Buy |
10,217
+4,451
| +77% | +$364K | 0.14% | 130 |
|
|
2021
Q1 | $434K | Buy |
5,766
+435
| +8% | +$31.7K | 0.08% | 221 |
|
|
2020
Q4 | $364K | Sell |
5,331
-290
| -5% | -$18.9K | 0.08% | 222 |
|
|
2020
Q3 | $328K | Sell |
5,621
-2,801
| -33% | -$174K | 0.08% | 239 |
|
|
2020
Q2 | $547K | Sell |
8,422
-1,017
| -11% | -$64K | 0.13% | 168 |
|
|
2020
Q1 | $560K | Sell |
9,439
-145
| -2% | -$9.68K | 0.17% | 138 |
|
|
2019
Q4 | $712K | Buy |
9,584
+7,810
| +440% | +$548K | 0.18% | 148 |
|
|
2019
Q3 | $112K | Sell |
1,774
-1,453
| -45% | -$86.1K | 0.03% | 391 |
|
|
2019
Q2 | $176K | Sell |
3,227
-290
| -8% | -$15.6K | 0.06% | 311 |
|
|
2019
Q1 | $190K | Sell |
3,517
-17,261
| -83% | -$1.07M | 0.07% | 272 |
|
|
2018
Q4 | $1.36M | Buy |
20,778
+20,510
| +7,653% | +$1.53M | 0.55% | 45 |
|
|
2018
Q3 | $21.4K | Hold |
268
| – | – | 0.01% | 467 |
|
|
2018
Q2 | $18.2K | Sell |
268
-1,616
| -86% | -$106K | 0.01% | 447 |
|
|
2018
Q1 | $117K | Buy |
+1,884
| New | +$135K | 0.04% | 326 |
|
Other funds holding CVS
Atlas Capital Advisors's CVS Position: Q2 2026 in Review
Atlas Capital Advisors reduced its CVS Health (CVS) stake by 6.8% in Q2 2026, selling an estimated $217K and leaving 33,386 shares worth $3.45M. The position accounts for 0.38% of the portfolio, ranked #70.
Atlas Capital Advisors first reported a position in CVS in Q1 2018 and has held it in 33 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Atlas Capital Advisors held 33,386 shares of CVS Health worth $3.45M as of Q2 2026.
- Atlas Capital Advisors sold 2,433 CVS Health shares in Q2 2026, an estimated $217K.
- CVS Health made up 0.38% of Atlas Capital Advisors's portfolio in Q2 2026, its #70 holding.
- Atlas Capital Advisors first reported a position in CVS Health in Q1 2018 and has held it in 33 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.